Adrenergic blocking and cardiovascular effects of a new N-substituted tetrahydroisoquinoline (NC 7197)
Privitera, P.J.; Blickenstaff, T.; Gaffney, T.E.; Mohammed, S.
Journal of Pharmacology and Experimental Therapeutics 176(3): 655-661
1971
ISSN/ISBN: 0022-3565 PMID: 4398744 Document Number: 34158
Document emailed within 1 workday
Related Documents
Bellomo, G.; Santucci, S.; Murrone, A.; Santambrogio, L.; Gennari, M.; Stangoni, G. 1988: Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity Panminerva Medica 30(4): 236-239Heer, S.; Femmer, K. 1980: On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol Die Pharmazie 34(5-6): 317-320
Balsamo, A.; Lapucci, A.; Macchia, B.; Macchia, M.; Orlandini, E.; Rossello, A.; Ferni, G.; Pinza, M. 1995: Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines Farmaco 50(4): 239-243
Gombar, V. 1986: Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols Arzneimittel-Forschung 36(7): 1014-1018
Nosál', R.; Drábiková, K.; Pecivová, J. 1988: Adverse effects of beta-adrenergic receptor blocking agents on the cellular level Casopis Lekaru Ceskych 127(5): 133-136
Apponi-Battini, G.; Barra, A.; De Simone, C.; Rossi, F.; Berrino, L.; Cazzola, M.; Marmo, E. 1984: Systemic and ocular effects of alpha 2-adrenergic stimulating and beta 2-blocking agents Journal of Medicine 15(2): 126-134
Charlier, R.; Delaunois, G.; Bauthier, J. 1972: Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation Arzneimittel-Forschung 22(3): 545-552
Singh, K.P. 1970: Some cardiovascular effects of 10-n substituted phenothiazine derivatives Indian Journal of Medical Research 58(3): 367-373
Ban, T. 1974: A quantitative study of the effects of isoproterenol and beta-adrenergic blocking agents in the rat uterus in situ Arzneimittel-Forschung 24(2): 179-181
Dufour, R.; Scazziga, B.; Schelling, J.L. 1970: Acute circulatory effects of a beta adrenergic blocking agent (LB 46) in patients with sympathetic overstimulation Internationale Zeitschrift für Klinische Pharmakologie Therapie und Toxikologie. International Journal of Clinical Pharmacology Therapy and Toxicology 4(1): 145-147
Ongini, E.; Milani, S.; Marzanatti, M.; Trampus, M.; Monopoli, A. 1991: Effects of selected beta-adrenergic blocking agents on sleep stages in spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 257(1): 114-119
Duggan, M.A.; Court, J.B. 1981: A proposed mechanism of production of the autoimmune and lymphoproliferative side-effects of beta-adrenergic-site-blocking drugs and hydantoin anticonvulsants Annals of Clinical Research 13(6): 406-418
Yoshida, T.; Takano, M.; Tamura, A.; Kubota, H.; Suzuki, N. 1970: Cardiovascular effects and antiarrhythmic action of a new beta adrenergic blocker, LB-46 Masui. Japanese Journal of Anesthesiology 19(5): 515-522
Holland, M.G. 1974: Autonomic drugs in ophthalmology: Some problems and promises. Section IV: Sympatholytic and sympathetic blocking agents--alpha adrenergic antagonists and beta adrenergic antagonists Annals of Ophthalmology 6(11): 1139-1142
Harms, H.H. 1976: Isoproterenol antagonism of cardioselective beta adrenergic receptor blocking agents: a comparative study of human and guinea-pig cardiac and bronchial beta adrenergic receptors Journal of Pharmacology and Experimental Therapeutics 199(2): 329-335
Bousquet, P.; Feldman, J.; Schwartz, J. 1984: Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines Journal of Pharmacology and Experimental Therapeutics 230(1): 232-236
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
Sugai, N.; Yajima, C.; Numata, K.; Irimada, T.; Hashimoto, Y.; Itagaki, T.; Katsumata, N.; Suzuki, H.; Aoki, T.; Fukushima, K. 1990: Evaluation of the action of pipecuronium bromide in patients under halothane anesthesia--a comparison with pancuronium bromide regarding their neuromuscular blocking and cardiovascular effects Masui. Japanese Journal of Anesthesiology 39(3): 293-300
Patnaik, G.K.; Srimal, R.C.; Das, P.K.; Dhawan, B.N. 1980: Evaluation of histamine H2 receptor blocking activity of a new 2-substituted pyrazinopyridoindole: diphenethindole Indian Journal of Experimental Biology 18(1): 39-44
Allen, G.S.; Gross, C.J. 1976: Cerebral arterial spasm. Part 7: in vitro effects of alpha adrenergic agents on canine arteries from six anatomical sites and six blocking agents on serotonin-induced contractions of the canine basilar artery Surgical Neurology 6(2): 63-70